Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
142 USD | +1.89% | +0.49% | +2.97% |
Financials (USD)
Sales 2024 * | 9.45B | Sales 2025 * | 9.76B | Capitalization | 15.77B |
---|---|---|---|---|---|
Net income 2024 * | 894M | Net income 2025 * | 962M | EV / Sales 2024 * | 2.1 x |
Net Debt 2024 * | 4.02B | Net Debt 2025 * | 3.55B | EV / Sales 2025 * | 1.98 x |
P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
16.7
x | Employees | 44,000 |
Yield 2024 * |
2.08% | Yield 2025 * |
2.11% | Free-Float | 68.24% |
Latest transcript on Quest Diagnostics Incorporated
1 day | +1.89% | ||
1 week | +0.49% | ||
1 month | +3.21% | ||
3 months | +13.87% | ||
6 months | +4.26% | ||
Current year | +2.97% |
Managers | Title | Age | Since |
---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 13-03-31 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 22-07-10 |
Kristin Wallace
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 19-02-17 |
Timothy Ring
BRD | Director/Board Member | 66 | 11-12-06 |
Gary Pfeiffer
BRD | Director/Board Member | 74 | 04-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.84% | 254 M€ | +13.69% | - | |
2.17% | 2 M€ | -.--% | ||
2.05% | 8 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 142 | +1.89% | 2,238,021 |
24-05-30 | 139.3 | +0.82% | 838,572 |
24-05-29 | 138.2 | -0.52% | 986,770 |
24-05-28 | 138.9 | -1.68% | 886,264 |
24-05-24 | 141.3 | +0.89% | 647,499 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.97% | 15.77B | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
-5.56% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B | |
+24.51% | 12.7B |
- Stock Market
- Equities
- DGX Stock